Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation

Stopped Pilot study with sumatriptan found no significant changes in the primary outcome parameter (change in CBF)

Conditions

• Healthy Volunteers

Interventions

• DRUG: Sumatriptan

Sponsor

Gitte Moos Knudsen